Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Equity

v3.20.2
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Class A Preferred Stock
Class A Common Shares
Common Shares
Common Stock Issuable
Additional Paid-in Capital
Accumulated Deficit
Total
Balances at Dec. 31, 2018     $ 3 $ 2,085 $ 113,378 $ (79,070) $ 36,396
Balances (in shares) at Dec. 31, 2018 250,000 1,000,000 26,610,183        
Issuance of common shares - Founders Agreement       (2,085) 2,085    
Issuance of common shares - Founders Agreement (in shares)     709,314        
Issuance of common shares - Equity fee on Horizon Notes to Fortress Biotech         375   375
Issuance of common shares - Equity fee on Horizon Notes to Fortress Biotech (in shares)     108,069        
Issuance of warrants - Horizon Notes         888   888
Conversion of Class A common shares to common shares (in shares)   (137,608) 137,608        
Issuance of common shares, net of offering costs - At-the-Market Offering         21,972   21,972
Issuance of common shares, net of offering costs - At-the-Market Offering (in Shares)     3,506,222        
Issuance of common shares - Equity fee on At-the-Market Offering         495   495
Issuance of common shares - Equity fee on At-the-Market Offering (in shares)     87,656        
Issuance of common shares, net of offering costs- Public Offering     $ 1   29,536   29,537
Issuance of common shares, net of offering costs- Public Offering (in shares)     7,906,250        
Issuance of common shares - Equity fee on Public Offering         791   791
Issuance of common shares - Equity fee on Public Offering (in shares)     197,656        
Stock-based compensation expenses         2,174   2,174
Stock-based compensation expenses (in shares)     222,477        
Exercise of warrants (in shares)     92,936        
Net loss           (30,180) (30,180)
Balances at Sep. 30, 2019     $ 4   171,694 (109,250) 62,448
Balances (in shares) at Sep. 30, 2019 250,000 862,392 39,578,371        
Balances at Jun. 30, 2019     $ 4   170,522 (99,082) 71,444
Balances (in shares) at Jun. 30, 2019 250,000 862,392 39,454,316        
Issuance of common shares, net of offering costs- Public Offering         52   52
Stock-based compensation expenses         1,120   1,120
Stock-based compensation expenses (in shares)     96,477        
Exercise of warrants (in shares)     27,578        
Net loss           (10,168) (10,168)
Balances at Sep. 30, 2019     $ 4   171,694 (109,250) 62,448
Balances (in shares) at Sep. 30, 2019 250,000 862,392 39,578,371        
Balances at Dec. 31, 2019     $ 4 4,923 172,184 (125,459) 51,652
Balances (in shares) at Dec. 31, 2019 250,000 845,385 39,403,519        
Issuance of common shares - Founders Agreement       (4,923) 4,923    
Issuance of common shares - Founders Agreement (in shares)     1,206,667        
Issuance of common shares, net of offering costs - At-the-Market Offering         25,083   25,083
Issuance of common shares, net of offering costs - At-the-Market Offering (in Shares)     7,180,437        
Issuance of common shares - Equity fee on At-the-Market Offering       235 417   652
Issuance of common shares - Equity fee on At-the-Market Offering (in shares)     117,405        
Issuance of common shares, net of offering costs- Public Offering     $ 1   34,786   34,787
Issuance of common shares, net of offering costs- Public Offering (in shares)     11,455,604        
Issuance of common shares - Equity fee on Public Offering         932   932
Issuance of common shares - Equity fee on Public Offering (in shares)     286,390        
Issuance of common shares under ESPP         349   $ 349
Issuance of common shares under ESPP (in shares)     140,856       140,856
Stock-based compensation expenses         2,368   $ 2,368
Stock-based compensation expenses (in shares)     370,662        
Exercise of warrants (in shares)     2,999        
Net loss           (39,407) (39,407)
Balances at Sep. 30, 2020     $ 5 235 241,042 (164,866) 76,416
Balances (in shares) at Sep. 30, 2020 250,000 845,385 60,164,539        
Balances at Jun. 30, 2020     $ 5   222,938 (151,914) 71,029
Balances (in shares) at Jun. 30, 2020 250,000 845,385 54,826,243        
Issuance of common shares, net of offering costs - At-the-Market Offering         17,240   17,240
Issuance of common shares, net of offering costs - At-the-Market Offering (in Shares)     5,044,803        
Issuance of common shares - Equity fee on At-the-Market Offering       235 215   450
Issuance of common shares - Equity fee on At-the-Market Offering (in shares)     64,015        
Issuance of common shares, net of offering costs- Public Offering         (137)   (137)
Issuance of common shares under ESPP         180   $ 180
Issuance of common shares under ESPP (in shares)     72,505       72,505
Stock-based compensation expenses         606   $ 606
Stock-based compensation expenses (in shares)     156,973        
Net loss           (12,952) (12,952)
Balances at Sep. 30, 2020     $ 5 $ 235 $ 241,042 $ (164,866) $ 76,416
Balances (in shares) at Sep. 30, 2020 250,000 845,385 60,164,539